Atazanavir
Reyataz (atazanavir) is a small molecule pharmaceutical. Atazanavir was first approved as Reyataz on 2003-06-20. It is used to treat acquired immunodeficiency syndrome in the USA. It has been approved in Europe to treat HIV infections.
| Trade Name | Reyataz |
|---|---|
| Common Name | Atazanavir |
| Indication | acquired immunodeficiency syndrome, hiv infections |
| Drug Class | Antivirals: HIV protease inhibitors (saquinavir type) |
